Topiramate
Product Images NDC 53002-1547

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 53002-1547). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01)

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01)
Chemical structure of Topiramate showing its molecular configuration including multiple oxygen atoms, sulfonamide group, and tert-butyl groups in a hexose ring framework.*
FDA Label Image

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02)

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02)
A line graph depicting cumulative rates for time to first seizure over a period of 500 days for Topiramate 50 mg/day and 400 mg/day doses. The y-axis shows cumulative rates, and the x-axis shows time in days. Two lines represent different dosages: a solid line for 50 mg/day and a dotted line for 400 mg/day, indicating varying seizure rates over time with a statistical p-value of 0.0002.*
FDA Label Image

Figure 2: Reduction In 4-week Migraine Headache Frequency(studies 10 And 11 For Adults And Adolescents) (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03)

Figure 2: Reduction In 4-week Migraine Headache Frequency(studies 10 And 11 For Adults And Adolescents) (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03)
A bar graph comparing change from baseline to double-blind phase in average monthly migraine period rate ±SE across placebo and three doses of Topamax (50 mg/day, 100 mg/day, 200 mg/day) in two studies. Study 10 and Study 11 are represented by separate bars. Statistical significance is indicated for higher doses with asterisks.*
FDA Label Image

Label Image (Lbl530021547)

Label Image (Lbl530021547)
Topiramate 50 mg tablets packaging label from RPK Pharmaceuticals, Inc., showing detailed information including drug name, strength, dosage form, quantity of 60 tablets, and instructions for use. The label includes barcodes, lot number, expiration date, and placeholders for clinic and prescription details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.